Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 526 across all filing types
Latest filing 2026-04-27 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 30% confidence The document is a formal regulatory announcement filed under SEBI Listing Regulation 30, summarizing outcomes of a Board Meeting including approval of audited financial results (quarterly & annual), declaration of final dividend, appointment of an independent director, allotment under ESOP, and project updates. It is not a standalone annual or interim report (it merely announces board approvals and encloses results), nor solely an earnings release, management change, or share issue notice. Therefore it falls under the general Regulatory Filings category (RNS).
2026-04-27 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed announcement from Rossari Biotech Limited dated April 27, 2026, reporting multiple corporate updates including the approval of audited financial results for the quarter and financial year ended March 31, 2026, declaration of final dividend, appointment of an additional independent director, allotment of equity shares under an employee stock option plan, updates on capacity addition project, and establishment of a new R&D facility. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and includes auditor's report with unmodified opinion on the financial statements. The document is lengthy (15,000 characters) and contains substantive financial data and corporate governance information. It is not merely an announcement of a report publication but includes actual financial results and multiple corporate actions. The presence of audited financial results and auditor's report indicates this is a comprehensive financial report for the fiscal year. Therefore, the document fits the definition of an Annual Report (10-K equivalent) rather than a simple announcement or regulatory filing. It also includes management and board changes but these are part of the broader annual reporting context. Hence, the best classification is Annual Report (10-K). FY 2026
2026-04-27 English
ESOP/ESOS/ESPS
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Rossari Biotech Limited dated April 27, 2026, reporting the outcome of a Board Meeting. It includes multiple items: approval of audited financial results for the quarter and financial year ended March 31, 2026, declaration of final dividend, appointment of an additional independent director, allotment of equity shares under an employee stock option plan, updates on capacity addition project, and setting up a new R&D facility. The document references compliance with SEBI Listing Regulations and includes auditor's report with unmodified opinion. The document is lengthy (15,000 characters) and contains substantive financial data (audited financial results and statements), management decisions, and corporate actions. It is not merely an announcement of a report or a certification letter. The presence of audited financial results and statements for the fiscal year indicates it is a comprehensive financial report. However, the document is not a full Annual Report (10-K) but rather a formal disclosure of audited financial results and related corporate updates typically filed as a quarterly or annual financial results announcement in India. Given the detailed financial results for the quarter and year, and the nature of the document, it fits best as an Interim / Quarterly Report (IR) type filing, which in Indian context often includes annual audited results as well. It is not a simple earnings release (ER) because it includes full audited financial statements and auditor's report. It also includes management and board changes but those are part of the broader board meeting outcome. Therefore, the best classification is Interim / Quarterly Report (IR). FY 2026
2026-04-27 English
Dividend
Regulatory Filings
2026-04-27 English
Outcome of Board Meeting
Regulatory Filings
2026-04-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015. It provides an update on the capacity addition project at the company's subsidiaries, indicating a rescheduling of the project timeline. The document is short (2548 characters) and serves as a regulatory disclosure or announcement rather than a detailed financial report or presentation. It does not contain financial statements, management discussion, or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.